Image

Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptability and feasibility.

Eligibility

Inclusion Criteria:

(Patients)

  • Alaska Native or American Indian person by self-report
  • eligible for or already receiving services at Southcentral Foundation (SCF)
  • age 18 years or older
  • daily smoking in the past 30-days
  • if other nicotine or tobacco products are used, cigarettes are main product used
  • planning to schedule an appointment with the Quit Tobacco Program to seek smoking cessation treatment in the next 30 days
  • willing to make a quit attempt within 30 days of enrollment in the Quit Tobacco Program
  • willing to have a blood test to inform their treatment
  • willing to try a pharmacologic treatment
  • willing to provide a saliva sample
  • has phone service
  • has access to broadband internet on mobile phone at home, work, or other location
  • has an Android or iPhone mobile phone compatible with the Smokerlyzer app

(Staff)

  • Staff participants of qualitative interviews to assess acceptability and feasibility of the intervention must be a health care professional at Southcentral Foundation (SCF), involved in the care of one of the participants of the study, that is their care team staff; including but not limited to: primary care providers, tobacco treatment specialists/health educators, pharmacists, nurse case managers, behavioral health consultants, certified medical assistants, and lab technicians.

Exclusion Criteria:

(Patients)

  • Participated in the prior study phase
  • participated in a cessation program during the past 3 months
  • their provider has not approved varenicline in their referral to the Quit Tobacco Program
  • has history of serious hypersensitivity or skin reactions to varenicline
  • has bleeding disorder or is currently receiving cancer treatment
  • questionable capacity or impaired decision-making capacity

Study details
    Smoking Cessation

NCT06556238

Southcentral Foundation

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.